Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele Morari

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
Frontiers in Molecular Neuroscience|June 7, 2014
LRRK2 kinase activity regulates synaptic vesicle trafficking and neurotransmitter release through modulation of LRRK2 macro-molecular complexMaria D Cirnaru, Antonella Marte, Elisa Belluzzi, et al.
Neurobiology of Aging|March 16, 2015
d-Aspartate oxidase influences glutamatergic system homeostasis in mammalian brainLuigia Cristino, Livio Luongo, Marta Squillace, et al.
Plos One|June 6, 2017
Role of LRRK2 in the regulation of dopamine receptor traffickingMauro Rassu, Maria Grazia Del Giudice, Simona Sanna, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 21, 2005
Blockade of nociceptin/orphanin FQ transmission attenuates symptoms and neurodegeneration associated with Parkinson's diseaseMatteo Marti, Flora Mela, Martina Fantin, et al.
Parkinsonism & Related Disorders|August 19, 2015
Chronic and acute LRRK2 silencing has no long-term behavioral effects, whereas wild-type and mutant LRRK2 overexpression induce motor and cognitive deficits and altered regulation of dopamine releaseMattia Volta, Stefano Cataldi, Dayne Beccano-Kelly, et al.
Cell Death & Disease|November 11, 2020
Pharmacological antagonism of kainate receptor rescues dysfunction and loss of dopamine neurons in a mouse model of human parkin-induced toxicityMaria Regoni, Stefano Cattaneo, Daniela Mercatelli, et al.
Brain : a Journal of Neurology|March 14, 2022
Brain injections of glial cytoplasmic inclusions induce a multiple system atrophy-like pathologyMargaux Teil, Sandra Dovero, Mathieu Bourdenx, et al.
Function (Oxford, England)|March 25, 2022
Mitochondrial P2X7 Receptor Localization Modulates Energy Metabolism Enhancing Physical PerformanceAlba Clara Sarti, Valentina Vultaggio-Poma, Simonetta Falzoni, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 29, 2004
[(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptorGiacomo Carrà, Anna Rizzi, Remo Guerrini, et al.
Brain : a Journal of Neurology|May 8, 2012
Mechanisms underlying the impairment of hippocampal long-term potentiation and memory in experimental Parkinson's diseaseCinzia Costa, Carmelo Sgobio, Sabrina Siliquini, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Frontiers in Molecular Neuroscience|June 7, 2014
LRRK2 kinase activity regulates synaptic vesicle trafficking and neurotransmitter release through modulation of LRRK2 macro-molecular complexMaria D Cirnaru, Antonella Marte, Elisa Belluzzi, et al.
Neurobiology of Aging|March 16, 2015
d-Aspartate oxidase influences glutamatergic system homeostasis in mammalian brainLuigia Cristino, Livio Luongo, Marta Squillace, et al.
Plos One|June 6, 2017
Role of LRRK2 in the regulation of dopamine receptor traffickingMauro Rassu, Maria Grazia Del Giudice, Simona Sanna, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 21, 2005
Blockade of nociceptin/orphanin FQ transmission attenuates symptoms and neurodegeneration associated with Parkinson's diseaseMatteo Marti, Flora Mela, Martina Fantin, et al.
Parkinsonism & Related Disorders|August 19, 2015
Chronic and acute LRRK2 silencing has no long-term behavioral effects, whereas wild-type and mutant LRRK2 overexpression induce motor and cognitive deficits and altered regulation of dopamine releaseMattia Volta, Stefano Cataldi, Dayne Beccano-Kelly, et al.
Cell Death & Disease|November 11, 2020
Pharmacological antagonism of kainate receptor rescues dysfunction and loss of dopamine neurons in a mouse model of human parkin-induced toxicityMaria Regoni, Stefano Cattaneo, Daniela Mercatelli, et al.
Brain : a Journal of Neurology|March 14, 2022
Brain injections of glial cytoplasmic inclusions induce a multiple system atrophy-like pathologyMargaux Teil, Sandra Dovero, Mathieu Bourdenx, et al.
Function (Oxford, England)|March 25, 2022
Mitochondrial P2X7 Receptor Localization Modulates Energy Metabolism Enhancing Physical PerformanceAlba Clara Sarti, Valentina Vultaggio-Poma, Simonetta Falzoni, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 29, 2004
[(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptorGiacomo Carrà, Anna Rizzi, Remo Guerrini, et al.
Brain : a Journal of Neurology|May 8, 2012
Mechanisms underlying the impairment of hippocampal long-term potentiation and memory in experimental Parkinson's diseaseCinzia Costa, Carmelo Sgobio, Sabrina Siliquini, et al.
Pageof 10